The Truth About Ketamine: Miracle Drug or Growing Menace?
Ketamine, long used as an animal tranquilizer and a party drug, has recently gained prominence as a rapidly-acting antidepressant. With depression being the leading global cause of disability, affecting over 300 million people worldwide, the emergence of a new, seemingly miraculous treatment has captured public attention.
However, this “wonder drug” may not be as benign as it seems on the surface. Originally approved as an anesthetic in the 1960s, ketamine has a concerning track record of recreational abuse. As it transitions from the fringes toward mainstream psychiatry, we must candidly examine its risks alongside the excitement of its benefits.
How Ketamine Works
The growing interest in ketamine therapy stems largely from its unique mechanism of action. Unlike commonly prescribed selective serotonin reuptake inhibitors (SSRIs) like Prozac or Zoloft, which can take 4-6 weeks to exert an effect, ketamine has been shown to alleviate depression in as little as two hours in some patients.
This ultra-fast action is attributed to ketamine’s activity blocking NMDA receptors. NMDA receptors interact with glutamate, a neurotransmitter implicated in synaptic plasticity, learning, and aspects of mood regulation. By immediately increasing glutamate transmission, ketamine is thought to initiate a cascade of changes at neuronal synapses that can rapidly improve communication and neuronal health.
This novel antidepressant mechanism spurred a flurry of research into ketamine’s effects on suicidal ideation, post-traumatic stress disorder (PTSD), obsessive thoughts, and other hard-to-treat mental health conditions. The results have often been described in glowing terms like “miraculous”, “unbelievable”, and “life-changing”.
As one long-time depression sufferer put it after her first infusion, “My life will be divided into the time before ketamine and the time after.”
The Dark Side of Dissociation
Yet for all its promise, ketamine carries significant risks. Most stem from its primary pharmacological effect: at higher doses, ketamine is a potent dissociative that can induce hallucinations, sensory distortions, and what is described psychologically as a “near death experience”. This intense, sometimes terrifying high can last up to 2 hours when abused recreationally.
And abuse ketamine unfortunately can. Beginning as a club drug in the 1980s, ketamine’s global recreational use has rapidly accelerated over the past decade. Today it is one of the most widely misused substances in the world. In Asia, ketamine use now exceeds that of opioids and amphetamines combined.
Fueling this dangerous trend are misperceptions that ketamine is relatively safe or benign due to its former use as an anesthesia medication in both humans and animals.
In reality, the line between its clinical and recreational doses is precariously thin. Ketamine’s dissociative mental state also carries major risks including panic attacks, psychosis, numbness, amnesia, irrational movements, and even death by respiratory depression.
These adverse effects have led the WHO to recommend tight control of ketamine while further research is conducted. Yet despite regulations, ketamine dependency and abuse rates continue to climb worldwide.
The Next Opioid Crisis?
Equally worrying is that long-term recreational use has been shown to cause symptoms essentially identical to early-stage schizophrenia in over 1 in 4 users. Visual and auditory hallucinations can persist for months afterwards, along with dissociative and delusional thinking.
Worldwide, experts have sounded warnings of a growing mental health crisis caused by ketamine addiction and psychosis resulting from widespread misuse.
“I have no doubts that in another 20 years time there are going to be lots of people with chronic depression, slumped over, dribbling, in wheelchairs, keratinized–because that’s what 20 years’ use of ketamine does to you. All for what? Because you tried to open Pandora’s box, thought you could control it?” said psychopharmacologist Dr. Lester Grinspoon of Harvard University.
Paralleling the early days of the opioid epidemic, liberal recreational use of ketamine also appears linked to increasing addiction rates and overdose deaths. Yet grassroots “self-treatment” with black market ketamine seems to be skyrocketing among desperate youth and millennials–likely making statistics on both very underreported.
Dr. Celia Morgan, psychopharmacology professor at University of Exeter supports cautious regulation going forward: “We need to think carefully about how to ensure potential antidepressant use remains medicalised, rather than following the trajectory of opioids or benzodiazepines into the realm of recreation.”
Rethinking A “Miracle Drug”
What then are we to make of this seemingly schizoaffective treatment? Is ketamine a dangerous substance that modern medicine is far too overzealous about bringing into practice? Or could oversight and management of its risks allow us to harness substantial benefits?
Clearly, placing a drug with severe dissociative and psychotropic effects into mainstream medical practice poses major ethical questions. Research thus far has mainly been limited to 6 doses over a few weeks, while long-term impacts of extended use are still unknown. Yet commercial treatment providers have already appeared offering expensive, open-ended maintenance “wellness” treatments to wealthy clients.
Regulators have their work cut out balancing calls to curb these exploitative and potentially dangerous business models versus denying access to those who could seriously benefit. As Madeleine Ritts, CEO of one New York clinic commented, “To limit something with such potential because some will abuse it is shortsighted.”
For Dr. Anna Gosline of Franklin University, the key is cultural: “I think a drug that helps open your mind has a lot of potential for abuse…Anything that’s used in excess is problematic. We just have to learn how to handle it.”
Future of Ketamine Therapy
While research continues on mitigation strategies like pairing psychotherapy with ketamine treatment or using alternative formulations to reduce misuse risk, clearly this genie is not going back into the bottle anytime soon.
Ketamine clinics are popping up from New York City to Silicon Valley at astounding rates. At the same time Chinese cartels are illegally exporting tons of ketamine powder worldwide. During the pandemic, use rates have skyrocketed.
In today’s fractured society, the yearning for a quick escape or cure often tragically outweighs rationale weighing of risks. And no amount of drug regulation can overcome these primal human drives for euphoria, inner peace, agency, or purpose.
Yet as with other drugs of both benefit and detriment, from alcohol to opioids, humanity has learned to walk these delicate lines before. With thoughtful policies, medical oversight, harm reduction education, and cultural maturation, perhaps in time we can too harness ketamine’s benefits while minimizing collateral damage.
About The Author
